Related Experiment Video
Updated: Jun 25, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Investigation into the application of remimazolamin conjunction with low-dose propofolfor pediatricfiberoptic
Wenjing Chen1, Wenjuan Bao2, Jing Shi2
1Department of Anesthesiology, Hebei Children's Hospital, No.133 Jianhua South Street, Shijiazhuang, 050031, Hebei, China. 15632332053@163.com.
Insights
Combining remimazolam with low-dose propofol for pediatric fiberoptic bronchoscopy offers stable hemodynamics and optimal conditions. This combination improves satisfaction and reduces adverse events compared to individual agents.
Area of Science:
- Anesthesiology
- Pediatric Pulmonology
- Pharmacology
Background:
- Pediatric fiberoptic bronchoscopy requires effective anesthesia for patient comfort and procedural success.
- Remimazolam and propofol are commonly used anesthetic agents, each with distinct pharmacokinetic and pharmacodynamic profiles.
- Optimizing anesthetic combinations can enhance safety and efficacy in pediatric procedures.
Purpose of the Study:
- To evaluate the efficacy and safety of combining remimazolam with low-dose propofol in pediatric fiberoptic bronchoscopy.
- To compare the hemodynamic stability, recovery profile, and procedural outcomes of this combination against monotherapy with remimazolam or propofol.
Main Methods:
- A prospective study involving 90 children undergoing fiberoptic bronchoscopy.
- Participants were randomized into three groups: remimazolam alone (Group R), propofol alone (Group P), and a combination of remimazolam with low-dose propofol (Group RP).
- Hemodynamic parameters (blood pressure, heart rate), oxygen saturation (SpO2), induction/recovery times, procedural success rates, cough scores, and patient satisfaction were assessed.
Main Results:
- Group P showed significantly lower blood pressure and heart rate post-anesthesia and during the procedure compared to Groups R and RP.
- Group P also exhibited lower SpO2 during the procedure and shorter induction/recovery times than Groups R and RP.
- The combination group (RP) demonstrated higher one-time success rates, lower cough scores, and superior patient satisfaction compared to the monotherapy groups.
Conclusions:
- Combining remimazolam with low-dose propofol provides balanced anesthesia, ensuring stable hemodynamics and optimal surgical conditions for pediatric fiberoptic bronchoscopy.
- This combination regimen leads to a lower incidence of adverse reactions and improved patient satisfaction.
- The synergistic effect of remimazolam and low-dose propofol presents a promising anesthetic strategy for pediatric bronchoscopic procedures.
Abstract:
This study delves into the effectiveness of combining remimazolam with low-dose propofol in pediatric fiberoptic bronchoscopy. Ninety children scheduled for fiberoptic bronchoscopy in our hospital were enrolled as research participants. Based on the intraoperative anesthetic drug regimen, the children were divided into three groups: group R (remimazolam 0.2-0.4 mg/kg), group P (propofol 1-3 mg/kg), and group RP (remimazolam0.2 mg/kg, propofol 0.5 mg/kg). Immediately post-anesthesia, group P exhibited lower blood pressure and heart rate (HR) compared to both group R and group RP (P < 0.05). As bronchoscope approached the glottis and epiglottis, group P continued to display lower blood pressure and HR compared to group R and group RP (P < 0.05). During lavage, group P maintained lower blood pressure and HR compared to both the R and RP groups (P < 0.05). Immediately post-anesthesia, group P demonstrated lower SpO2 compared to the R and RP groups (P < 0.05).During lavage, group P maintained lower SpO2 than group R and group RP (P < 0.05). In comparison with group R and group PR, group P showed shortened induction and recovery times (P < 0.05). The one-time entry success rate into the microscope was higher in group R than in group P, with the RP group showing an intermediate decreased (P < 0.05). Moreover, the cough score in R group was higher than in the P and RP groups (P < 0.05). Furthermore, the satisfaction rates of the RP group exceeded those of the R and P groups (P < 0.05). Remimazolam combined with low-dose propofol effectively balances the strengths and weaknesses of remimazolam and propofol, ensuring more stable hemodynamics, a lower incidence of adverse reactions, and optimal surgical conditions in pediatric fiberoptic bronchoscopy.
More Related Videos
05:43Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow
Published on: January 13, 2017
08:38Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
Related Concept Videos
Inhalational Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Therapeutic Uses